South Africa Confirms Second Guillain-Barré Syndrome Death Due to COVID Vaccine

South Africa Confirms Second Guillain-Barré Syndrome Death Due to COVID Vaccine

The South African Health Products Regulatory Authority (SAHPRA) confirmed on Sept. 12, 2022 that another person in South Africa has died of a polio-like neurological disorder that causes paralysis known as Guillain-Barré syndrome (GBS) due to receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. SAHPRA said the National Immunization Safety Expert Committee (NISEC) performed […]

German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions

German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions

Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]

Death in South Africa Causally Linked to Johnson & Johnson COVID Vaccine

Death in South Africa Causally Linked to Johnson & Johnson COVID Vaccine

On Aug. 4, 2022, the South African Health Products Regulatory Authority (SAHPRA) reported the death of an individual in South Africa shortly after receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. The agency stated that the death was causally linked to the vaccine.1 2 3 4 5 The name and age of the person […]

FDA Grants EUA for Novavax’s COVID Vaccine

FDA Grants EUA for Novavax’s COVID Vaccine

Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]

FDA Panel Recommends EUA for Novavax COVID-19 Vaccine

FDA Panel Recommends EUA for Novavax COVID-19 Vaccine

Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]

Guillain-Barré Syndrome Linked to COVID-19 Shots

Guillain-Barré Syndrome Linked to COVID-19 Shots

A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]

FDA Approves Fourth COVID Shot. Fifth Shot Considered.

FDA Approves Fourth COVID Shot. Fifth Shot Considered.

On Mar. 29, 2022, the U.S. Food and Drug Administration (FDA) approved a second booster dose (a fourth shot) of the Pfizer/BioNTech messenger RNA (mRNA) biologic BNT162b2 (“Comirnaty”) and Moderna/NIAID mRNA-1273 (“Spikevax”) for people 50 years of age and older, as well as younger individuals who are immunocompromised. The second booster would be given no […]

Autoimmune Bleeding Disorder Diagnosed After COVID Shots

Autoimmune Bleeding Disorder Diagnosed After COVID Shots

Four cases of an autoimmune bleeding disorder known as acquired hemophilia (AHA) were diagnosed in Italy’s northern province of Reggio Emilia weeks after the individuals received Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) biologic. The report about these four cases was published in a letter to the editors of journal Thrombosis Research […]

NIH-Funded Study Found COVID-19 Shots Impact Menstrual Cycles

NIH-Funded Study Found  COVID-19 Shots Impact Menstrual Cycles

A U.S. cohort study assessing the effect of COVID-19 shots on menstrual cycles was peer reviewed and published in the journal Obstetrics & Gynecology on Jan. 5, 20221 after many  women spoke out about changes to their menstrual cycles after receiving COVID shots. The U.S. National Institutes of Health (NIH) provided $1.6 million to fund […]

Hearing Loss and Tinnitus May Be Linked to COVID Vaccination

Hearing Loss and Tinnitus May Be Linked to COVID Vaccination

A new study published in the journal JAMA Otolaryngology-Head & Neck Surgery published on Feb. 24, 2022 has found a possible association between Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic and sudden sensorineural hearing loss (SSNHL). The retrospective cohort study of 2 ,602, 557 patients in Israel suggested a slight increased risk of SSNHL.1 […]

1 2 3